Episode
LCC Beyond Stage IV: Rethinking Oligometastatic Lung Cancer
- Podcast
- Lung Cancer Considered
- Published
- May 8, 2026
- Duration seconds
- 2850
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/lung-cancer-considered-246259/episodes/lcc-beyond-stage-iv-rethinking-oligometastatic-lung-cancer/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/lung-cancer-considered-246259/lcc-beyond-stage-iv-rethinking-oligometastatic-lung-cancer.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This episode of Lung Cancer considered explores the evolving management of oligometastatic lung cancer. They break down key definitions, discuss when and how to use consolidative therapies like radiation and surgery, and examine patient selection, limitations, and emerging tools such as ctDNA that are shaping a more precise approach to care. Guests: Dr. Yasir Elamin is a thoracic/head and neck medical oncology fellowship director and associate professor in the department of thoracic/head and neck medical oncology at the University of Texas MD Anderson Cancer Center. Dr. Lilian Faroni is a thoracic radiation oncologist atClínica São Vicente - Oncologia D'Orfrom Rio de Janeiro, Brazil. She specializes in the care of patients with oligometastatic lung cancer from oligopersistent to oligoprogressive disease.